Lv11
36 积分 2024-04-09 加入
Ambroxol, a Nav1.8-preferring Na+ channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain
30天前
已完结
Drug discovery targeting Nav1.8: Structural insights and therapeutic potential
1个月前
已完结
Exploring the therapeutic utility of the factor XIa inhibitor asundexian
1个月前
已完结
Conotoxins targeting voltage-gated sodium ion channels
1个月前
已完结
Structural biology and molecular pharmacology of voltage-gated ion channels
1个月前
已完结
Chronic pain: an update on burden, best practices, and new advances
2个月前
已完结
The NaV1.8-Collapsin Response Mediator Protein 5 Interaction Regulates NaV1.8 Membrane Localization and Nociception
2个月前
已关闭
Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds
3个月前
已完结
Antimicrobial peptides: Structure, mechanism, and modification
3个月前
已完结
Vertex’s non-opioid painkiller passes phase III tests
3个月前
已完结
皖公网安备34019202002308
